Simpson–Golabi–Behmel syndrome

Alessandro Vaisfeld,Giovanni Neri

DOI: https://doi.org/10.1002/ajmg.c.32088

2024-05-22

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity

What problem does this paper attempt to address?

Phenotypic spectrum and tumor risk in Simpson‐Golabi‐Behmel syndrome: Case series and comprehensive literature review

Alex F. Nisbet,Aravind Viswanathan,Andrew M. George,Pedro Arias,Steven D. Klein,Julian Nevado,Alejandro Parra,Patricia Pascual,Dominic J. Romeo,Jair Tenorio‐Castaño,Jesse A. Taylor,Elaine H. Zackai,Pablo Lapunzina,Jennifer M. Kalish

DOI: https://doi.org/10.1002/ajmg.a.63840

2024-08-21

American Journal of Medical Genetics Part A

Abstract:Simpson‐Golabi‐Behmel syndrome (SGBS) is a rare congenital overgrowth condition characterized by macrosomia, macroglossia, coarse facial features, and development delays. It is caused by pathogenic variants in the GPC3 gene on chromosome Xq26.2. Here, we performed a comprehensive literature review and phenotyping of known patients with molecularly confirmed SGBS and reviewed a novel cohort of 22 patients. Using these data, we characterized the tumor risk for Wilms tumor and hepatoblastoma to suggest appropriate screening for this patient population. In addition, we discuss the phenotypic overlap between SGBS and Beckwith‐Wiedemann Spectrum.

genetics & heredity
CUGC for Simpson-Golabi-Behmel syndrome (SGBS)

Marie-Laure Vuillaume,Marie-Pierre Moizard,Alessandra Baumer,Edouard Cottereau,Frédéric Brioude,Anita Rauch,Annick Toutain

DOI: https://doi.org/10.1038/s41431-019-0339-z

2019-01-25

European Journal of Human Genetics

Abstract:Name of the disease (Synonyms):Simpson-Golabi-Behmel syndrome (SGBS).OMIM# of the disease:312870.Name of the analysed genes or DNA/chromosome segments:GPC3.OMIM# of the gene(s):300037.Review of the analytical and clinical validity as well as of the clinical utility of DNA-based testing for mutations in the GPC3 gene(s) in⊠diagnostic,☐predictive and⊠prenatal settings and for⊠risk assessment in relatives.

genetics & heredity,biochemistry & molecular biology
Blepharophimosis with intellectual disability and Helsmoortel‐Van Der Aa Syndrome share episignature and phenotype

Camilla Sarli,Liselot van der Laan,Jack Reilly,Slavica Trajkova,Diana Carli,Alfredo Brusco,Michael A. Levy,Raissa Relator,Jennifer Kerkhof,Haley McConkey,Matthew L. Tedder,Cindy Skinner,Mariëlle Alders,Peter Henneman,Raoul C. M. Hennekam,Claudia Ciaccio,Stefano D'Arrigo,Antonio Vitobello,Laurence Faivre,Sacha Weber,Aline Vincent‐Devulder,Laurence Perrin,Alexia Bourgois,Toshiyuki Yamamoto,Kay Metcalfe,Marcella Zollino,Usha Kini,Daniela Oliveira,Sergio B. Sousa,Denise Williams,Gerarda Cappuccio,Bekim Sadikovic,Nicola Brunetti‐Pierri

DOI: https://doi.org/10.1002/ajmg.c.32089

2024-06-19

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity
Cognitive, Social, and Emotional‐Behavioral Outcomes in Children and Adolescents With Beckwith–Wiedemann Syndrome

Niccolò Butti,Cosimo Urgesi,Alessandro Mussa,Rosario Montirosso

DOI: https://doi.org/10.1002/ajmg.b.33006

2024-09-27

American Journal of Medical Genetics Part B Neuropsychiatric Genetics

Abstract:American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.

genetics & heredity,psychiatry
A Novel Compound Heterozygous Variant of the SLC12A3 Gene in Gitelman Syndrome Pedigree

Yixin Chen,Ziyi Zhang,Xihua Lin,Qianqian Pan,Fenping Zheng,Hong Li

DOI: https://doi.org/10.1186/s12881-018-0527-7

2018-01-01

BMC Medical Genetics

Abstract:Background: Gitelman syndrome (GS) is an autosomal recessive disorder caused by genic mutations of SLC12A3 (Solute carrier family 12 member 3), which encodes the Na-Cl cotransporter (NCC), and presents with characteristic metabolic abnormalities, including hypokalemia, metabolic alkalosis, hypomagnesemia, and hypocalciuria. In this study, we report a case of a GS pedigree, including analysis of GS-associated gene mutations. Methods: We performed next-generation sequencing analysis and Sanger sequencing to explore the SLC12A3 mutations in a GS pedigree that included a 35-year-old female patient with GS and five family members within three generations. Furthermore, we summarized their clinical manifestations and analyzed laboratory parameters related to GS. Results: The female proband (the patient with GS) presented with intermittent fatigue and transient periods of tetany, along with significant hypokalemia, hypomagnesemia, and hypocalciuria. All other members of the pedigree had normal laboratory results without obvious GS-related symptoms. Genetic analysis of the SLC12A3 gene identified two novel missense mutations (c.1919A > G, p.N640S in exon 15; c.2522A > G, p.D841G in exon 21) in the patient with GS. Moreover, we demonstrated that her mother, younger maternal uncle, and cousin were carriers of one mutation (c.1919A > G), and her father was the carrier of the other (c.2522A > G). Conclusion: This is the first report of these two novel pathogenic variants of SLC12A3 and their contribution to GS. Further functional studies are particularly warranted to explore the underlying molecular mechanisms.
Identification by Whole Genome Sequencing and Joint Analysis

Mario Cuk,Busra Unal,Nives Jandrica,Connor P. Hayes,McKenzie Walker,Feruza Abraamyan,Kristina Crkvenac Gornik,Arezou A. Ghazani

DOI: https://doi.org/10.3390/jpm14090901

IF: 3.5083

2024-08-27

Journal of Personalized Medicine

Abstract:Smith–Magenis syndrome is a complex neurobehavioral genetic disorder with a broad phenotypic spectrum. While the etiology of SMS is commonly attributed to one-copy interstitial deletion in the 17p11.2 region (90–95% of cases), variants identified by sequence analysis in RAI1 have also been reported in 5–10% of cases. In this study, we report a 9-year-old male with global cognitive and psychomotor developmental delay, musculoskeletal and cardiovascular abnormalities, and dysmorphic craniofacial features. Joint analysis was performed on the whole-genome sequencing data obtained from the proband, unaffected parents, and unaffected brother. This quad analysis identified the novel de novo RAI1:c.2736delC variant. This is the first report of this variant in the literature. This report highlights the details of genome analysis and the patient's phenotypic spectrum.

medicine, general & internal,health care sciences & services
A SMARCA2 Mutation in the First Case Report of Nicolaides-Baraitser Syndrome in Latin America: Genotype-Phenotype Correlation

Ana Isabel Sánchez,Jorge Armando Rojas

DOI: https://doi.org/10.1155/2017/8639617

2017-01-01

Case Reports in Genetics

Abstract:Nicolaides-Baraitser syndrome (NCBRS) is a rare and well-recognized entity that was first described in 1993, with a prevalence that is currently not known. It is recognized as a distinctive entity, with some variability in its signs and symptoms. The most important characteristics include intellectual disability, peculiar facial features including sparse scalp hair, coarse facial features, low frontal hairline, and microcephaly, and seizures. Additional features may include epicanthic folds, thin upper lip vermilion with thick lower lip vermilion, skeletal abnormalities, and severe language impairment. The disorder is inherited in an autosomal dominant manner caused by de novo mutations in the SMARCA2 gene, with most being missense mutations. We report a young adult patient with NCBRS and, to our knowledge, the first case report of the syndrome in Latin America with a confirmed molecular diagnosis and a mild-to-moderate phenotype.
Biallelic variants in GTPBP3: New patients, phenotypic spectrum, and outcome

Francesca Nardecchia,Rosalba Carrozzo,Alice Innocenti,Alessandra Torraco,Valerio Zaccaria,Teresa Rizza,Francesco Pisani,Enrico Bertini,Vincenzo Leuzzi

DOI: https://doi.org/10.1002/acn3.51980

IF: 5.43

2024-02-09

Annals of Clinical and Translational Neurology

Abstract:Introduction COXPD23 is a rare mitochondrial disease caused by biallelic pathogenic variants in GTPBP3. We report on two siblings with a mild phenotype. Case reports The young boy presented with global developmental delay, ataxic gait and upper limbs tremor, and the older sister with absence seizures and hypertrophic cardiomyopathy. Respiratory chain impairment was confirmed in muscle. Discussion Reviewed cases point toward clustering around two prevalent phenotypes: an early‐onset presentation with severe fatal encephalopathy and a late milder presentation with global developmental delay/ID and cardiopathy, with the latter as, is the main feature. Our patients showed an intermediate phenotype with intrafamilial variability.

neurosciences,clinical neurology
Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol

Simone Gasparini,Simona Balestrini,Luigi Francesco Saccaro,Giacomo Bacci,Giorgia Panichella,Martino Montomoli,Gaetano Cantalupo,Stefania Bigoni,Giorgia Mancano,Simona Pellacani,Vincenzo Leuzzi,Nila Volpi,Francesco Mari,Federico Melani,Mara Cavallin,Tiziana Pisano,Giulio Porcedda,Augusto Vaglio,Davide Mei,Carmen Barba,Elena Parrini,Renzo Guerrini

DOI: https://doi.org/10.1002/ajmg.c.32099

2024-07-19

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity
Epigenomic and phenotypic characterization of DEGCAGS syndrome

Karim Karimi,Denisa Weis,Ingvild Aukrust,Tzung-Chien Hsieh,Marie Horackova,Julie Paulsen,Roberto Mendoza Londono,Lucie Dupuis,Megan Dickson,Hellen Lesman,Tracy Lau,David Murphy,Khalid Hama Salih,Bassam M. S. Al-Musawi,Ruqayah G. Y. Al-Obaidi,Malgorzata Rydzanicz,Mateus Biela,Mafalda Saraiva Santos,Abdulrahman Aldeeri,Hanna T. Gazda,Lynn Pais,Shirlee Shril,Henrik Døllner,Sandip Bartakke,Franco Laccone,Andrea Soltysova,Thomas Kitzler,Neveen A. Soliman,Raissa Relator,Michael A. Levy,Jennifer Kerkhof,Jessica Rzasa,Henry Houlden,Gabriela V. Pilshofer,Tilman Jobst-Schwan,Friedhelm Hildebrandt,Sergio B. Sousa,Reza Maroofian,Timothy W. Yu,Peter Krawitz,Bekim Sadikovic,Sofia Douzgou Houge

DOI: https://doi.org/10.1038/s41431-024-01702-y

2024-10-20

European Journal of Human Genetics

Abstract:Developmental Delay with Gastrointestinal, Cardiovascular, Genitourinary, and Skeletal Abnormalities syndrome (DEGCAGS, MIM #619488) is caused by biallelic, loss-of-function (LoF) ZNF699 variants, and is characterized by variable neurodevelopmental disability, discordant organ anomalies among full siblings and infant mortality. ZNF699 encodes a KRAB zinc finger protein of unknown function. We aimed to investigate the genotype-phenotype spectrum of DEGCAGS and the possibility of a diagnostic DNA methylation episignature, to facilitate the diagnosis of a highly variable condition lacking pathognomonic clinical findings. We collected data on 30 affected individuals (12 new). GestaltMatcher analyzed fifty-three facial photographs from five individuals. In nine individuals, methylation profiling of blood-DNA was performed, and a classification model was constructed to differentiate DEGCAGS from controls. We expand the ZNF699 -related molecular spectrum and show that biallelic, LoF, ZNF699 variants cause unique clinical findings with age-related presentation and a similar facial gestalt. We also identified a robust episignature for DEGCAGS syndrome. DEGCAGS syndrome is a clinically variable recessive syndrome even among siblings with a distinct methylation episignature which can be used as a screening, diagnostic and classification tool for ZNF699 variants. Analysis of differentially methylated regions suggested an effect on genes potentially implicated in the syndrome's pathogenesis.

genetics & heredity,biochemistry & molecular biology
New Insights Into TRMT10A Syndrome: Case Report and Literature Review

Graziana Ceraolo,Giulia Spoto,Ambra Butera,Maria Spanò,Mirella Vinci,Girolamo Aurelio Vitello,Antonino Musumeci,Francesco Calì,Antonio Gennaro Nicotera,Gabriella Di Rosa

DOI: https://doi.org/10.1002/ajmg.b.33015

2024-10-25

American Journal of Medical Genetics Part B Neuropsychiatric Genetics

Abstract:American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.

genetics & heredity,psychiatry
Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants

Li Xin Zhang,Gabrielle Lemire,Claudia Gonzaga-Jauregui,Sirinart Molidperee,Carolina Galaz-Montoya,David S. Liu,Alain Verloes,Amelle G. Shillington,Kosuke Izumi,Alyssa L. Ritter,Beth Keena,Elaine Zackai,Dong Li,Elizabeth Bhoj,Jennifer M. Tarpinian,Emma Bedoukian,Mary K. Kukolich,A. Micheil Innes,Grace U. Ediae,Sarah L. Sawyer,Karippoth Mohandas Nair,Para Chottil Soumya,Kinattinkara R. Subbaraman,Frank J. Probst,Jennifer A. Bassetti,Reid V. Sutton,Richard A. Gibbs,Chester Brown,Philip M. Boone,Ingrid A. Holm,Marco Tartaglia,Giovanni Battista Ferrero,Marcello Niceta,Maria Lisa Dentici,Francesca Clementina Radio,Boris Keren,Constance F. Wells,Christine Coubes,Annie Laquerrière,Jacqueline Aziza,Charlotte Dubucs,Sheela Nampoothiri,David Mowat,Millan S. Patel,Ana Bracho,Francisco Cammarata-Scalisi,Alper Gezdirici,Alberto Fernandez-Jaen,Natalie Hauser,Yuri A. Zarate,Katherine A. Bosanko,Klaus Dieterich,John C. Carey,Jessica X. Chong,Deborah A. Nickerson,Michael J. Bamshad,Brendan H. Lee,Xiang-Jiao Yang,James R. Lupski,Philippe M. Campeau

DOI: https://doi.org/10.1038/s41436-020-0811-8

IF: 8.864

2020-08-01

Genetics in Medicine

Abstract:Genitopatellar syndrome and Say–Barber–Biesecker–Young–Simpson syndrome are caused by variants in the <i>KAT6B</i> gene and are part of a broad clinical spectrum called <i>KAT6B</i> disorders, whose variable expressivity is increasingly being recognized.

genetics & heredity
Low‐grade parental gonosomal mosaicism in CHD2 siblings with Smith–Magenis‐like syndrome

Francesca Cogliati,Letizia Straniero,Valeria Rimoldi,Maura Masciadri,Sara Perego,Berardo Rinaldi,Donatella Milani,Davide Gentilini,Lidia Larizza,Rosanna Asselta,Silvia Russo,Maria Francesca Bedeschi

DOI: https://doi.org/10.1002/ajmg.b.32976

2024-02-23

American Journal of Medical Genetics Part B Neuropsychiatric Genetics

Abstract:American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.

genetics & heredity,psychiatry
[Unusual Facies with Delayed Development and Multiple Malformations in a 14-Month-old Boy].

Tong Lu,Yi Wang

DOI: https://doi.org/10.7499/j.issn.1008-8830.2017.08.014

2017-01-01

Abstract:Schinzel-Giedion syndrome is a rare autosomal dominant genetic disease and has the clinical features of severe delayed development, unusual facies, and multiple congenital malformations. In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the hip joint, and cryptorchidism). The karyotype analysis and copy number variations showed no abnormalities, and whole exon sequencing showed a de novo heterozygous missense mutation, c.2602G > A (p. D868N), in SETBP1 gene. Therefore, the boy was diagnosed with Schinzel-Giedion syndrome. Myoclonic seizures in this boy were well controlled by sodium valproate treatment, and his language development was also improved after rehabilitation treatment. Clinical physicians should improve their ability to recognize such rare diseases, and Schinzel-Giedion syndrome should be considered for children with unusual facies, delayed development, and multiple malformations. Gene detection may help with the diagnosis of this disease.
Novel homozygous OSGEP gene pathogenic variants in two unrelated patients with Galloway-Mowat syndrome: case report and review of the literature

Andrea Domingo-Gallego,Mónica Furlano,Marc Pybus,Daniel Barraca,Ana Belén Martínez,Emiliano Mora Muñoz,Roser Torra,Elisabet Ars

DOI: https://doi.org/10.1186/s12882-019-1317-y

2019-04-11

BMC Nephrology

Abstract:BackgroundGalloway-Mowat syndrome (GAMOS) is a rare autosomal recessive disorder characterized by early-onset nephrotic syndrome and microcephaly with brain anomalies. WDR73 pathogenic variants were described as the first genetic cause of GAMOS and, very recently, four novel causative genes, OSGEP, LAGE3, TP53RK, and TPRKB, have been identified.

urology & nephrology
Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics

Maria Nicla Loviglio,Christine R. Beck,Janson J. White,Marion Leleu,Tamar Harel,Nicolas Guex,Anne Niknejad,Weimin Bi,Edward S. Chen,Isaac Crespo,Jiong Yan,Wu-Lin Charng,Shen Gu,Ping Fang,Zeynep Coban-Akdemir,Chad A. Shaw,Shalini N. Jhangiani,Donna M. Muzny,Richard A. Gibbs,Jacques Rougemont,Ioannis Xenarios,James R. Lupski,Alexandre Reymond

DOI: https://doi.org/10.1186/s13073-016-0359-z

IF: 15.266

2016-11-01

Genome Medicine

Abstract:BackgroundSmith-Magenis syndrome (SMS) is a developmental disability/multiple congenital anomaly disorder resulting from haploinsufficiency of RAI1. It is characterized by distinctive facial features, brachydactyly, sleep disturbances, and stereotypic behaviors.MethodsWe investigated a cohort of 15 individuals with a clinical suspicion of SMS who showed neither deletion in the SMS critical region nor damaging variants in RAI1 using whole exome sequencing. A combination of network analysis (co-expression and biomedical text mining), transcriptomics, and circularized chromatin conformation capture (4C-seq) was applied to verify whether modified genes are part of the same disease network as known SMS-causing genes.ResultsPotentially deleterious variants were identified in nine of these individuals using whole-exome sequencing. Eight of these changes affect KMT2D, ZEB2, MAP2K2, GLDC, CASK, MECP2, KDM5C, and POGZ, known to be associated with Kabuki syndrome 1, Mowat-Wilson syndrome, cardiofaciocutaneous syndrome, glycine encephalopathy, mental retardation and microcephaly with pontine and cerebellar hypoplasia, X-linked mental retardation 13, X-linked mental retardation Claes-Jensen type, and White-Sutton syndrome, respectively. The ninth individual carries a de novo variant in JAKMIP1, a regulator of neuronal translation that was recently found deleted in a patient with autism spectrum disorder. Analyses of co-expression and biomedical text mining suggest that these pathologies and SMS are part of the same disease network. Further support for this hypothesis was obtained from transcriptome profiling that showed that the expression levels of both Zeb2 and Map2k2 are perturbed in Rai1–/– mice. As an orthogonal approach to potentially contributory disease gene variants, we used chromatin conformation capture to reveal chromatin contacts between RAI1 and the loci flanking ZEB2 and GLDC, as well as between RAI1 and human orthologs of the genes that show perturbed expression in our Rai1–/– mouse model.ConclusionsThese holistic studies of RAI1 and its interactions allow insights into SMS and other disorders associated with intellectual disability and behavioral abnormalities. Our findings support a pan-genomic approach to the molecular diagnosis of a distinctive disorder.

genetics & heredity
Diffuse subcortical band heterotopia, periodic limb movements during sleep and a novel "de novo" mutation in the DCX gene

Pasquale Parisi,Silvia Miano,Davide Mei,Maria Chiara Paolino,Rosa Castaldo,Maria Pia Villa

DOI: https://doi.org/10.1016/j.braindev.2009.06.007

Abstract:Mutations of the DCX gene (Xp22.3) cause X-linked lissencephaly in males and double cortex syndrome (DCS) or subcortical band heterotopia (SBH) in females. SBH is characterized by bilateral bands of grey matter interposed in the white matter between the cortex and the lateral ventricles. The main clinical manifestation in patients with SBH is epilepsy, which may be partial or generalized and is intractable in approximately 65% of the patients. An association of periodic limb movements (PLMs) and SBH has not been documented previously. We describe a 2-year-old girl affected by SBH with epilepsy and periodic limb movements (PLMs), in whom a novel "de novo" missense substitution, Met1Val (M1V), was identified in the DCX gene. Physiopathological links between PLMs and SBH are discussed.
SMC1A epilepsy syndrome: clinical data from a large international cohort

Elisabetta Gibellato,Paola Cianci,Milena Mariani,Barbara Parma,Sylvia Huisman,Robert Śmigiel,Anne‐Marie Bisgaard,Valentina Massa,Cristina Gervasini,Alex Moretti,Alessandro Cattoni,Andrea Biondi,Angelo Selicorni

DOI: https://doi.org/10.1002/ajmg.a.63577

2024-03-02

American Journal of Medical Genetics Part A

Abstract:SMC1A epilepsy syndrome or developmental and epileptic encephalopathy‐85 with or without midline brain defects (DEE85, OMIM #301044) is an X‐linked neurologic disorder associated with mutations of the SMC1A gene, which is also responsible for about 5% of patients affected by Cornelia de Lange syndrome spectrum (CdLS). Only described in female patients, SMC1A epilepsy syndrome is characterized by the onset of severe refractory epileptic seizures in the first year of life, global developmental delay, a variable degree of intellectual disability, and dysmorphic facial features not typical of CdLS. This was a descriptive observational study for the largest international cohort with this specific disorder. The main goal of this study was to improve the knowledge of the natural history of this phenotype with particular attention to the psychomotor development and the epilepsy data. The analyzed cohort shows normal prenatal growth with the subsequent development of postnatal microcephaly. The incidence of neonatal problems (seizures and respiratory compromise) is considerable (51.4%). There is a significant prevalence of central nervous system (20%) and cardiovascular malformations (20%). Motor skills are generally delayed. The presence of drug‐resistant epilepsy is confirmed; the therapeutic role of a ketogenic diet is still uncertain. The significant regression of previously acquired skills following the onset of seizures has been observed. Facial dysmorphisms are variable and no patient shows a classic CdLS phenotype. To sum up, SMC1A variants caused drug‐resistant epilepsy in these patients, more than two‐thirds of whom were shown to progress to developmental and epileptic encephalopathy. The SMC1A gene variants are all different from each other (apart from a couple of monozygotic twins), demonstrating the absence of a mutational hotspot in the SMC1A gene. Owing to the absence of phenotypic specificity, whole‐exome sequencing is currently the diagnostic gold standard.

genetics & heredity
Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

Jenny P. Garzon,Andrea Patete,Lindsey Aschbacher‐Smith,Dima Qu'd,Geraldine Kelly‐Mancuso,Carolyn R. Raski,Allison Goetsch Weisman,Madison Hankins,Michael Sawin,Katherine Kim,Andy Drackley,Janice Zeid,K. Nicole Weaver,Robert J. Hopkin,Howard M. Saal,Joel Charrow,Elizabeth Schorry,Robert Listernick,Brittany N. Simpson,Carlos E. Prada

DOI: https://doi.org/10.1002/ajmg.c.32095

2024-07-20

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity
Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia

Radha Procopio,Francesco Fortunato,Monica Gagliardi,Mariagrazia Talarico,Ilaria Sammarra,Maria Chiara Sarubbi,Donatella Malanga,Grazia Annesi,Antonio Gambardella

DOI: https://doi.org/10.3390/ijms25105505

2024-05-18

Abstract:Doublecortin, encoded by the DCX gene, plays a crucial role in the neuronal migration process during brain development. Pathogenic variants of the DCX gene are the major causes of the "lissencephaly (LIS) spectrum", which comprehends a milder phenotype like Subcortical Band Heterotopia (SBH) in heterozygous female subjects. We performed targeted sequencing in three unrelated female cases with SBH. We identified three DCX-related variants: a novel missense (c.601A>G: p.Lys201Glu), a novel nonsense (c.210C>G: p.Tyr70*), and a previously identified nonsense (c.907C>T: p.Arg303*) variant. The novel c.601A>G: p.Lys201Glu variant shows a mother-daughter transmission pattern across four generations. The proband exhibits focal epilepsy and achieved seizure freedom with a combination of oxcarbazepine and levetiracetam. All other affected members have no history of epileptic seizures. Brain MRIs of the affected members shows predominant fronto-central SBH with mixed pachygyria on the overlying cortex. The two nonsense variants were identified in two unrelated probands with SBH, severe drug-resistant epilepsy and intellectual disability. These novel DCX variants further expand the genotypic-phenotypic correlations of lissencephaly spectrum disorders. Our documented phenotypic descriptions of three unrelated families provide valuable insights and stimulate further discussions on DCX-SBH cases.

Simpson–Golabi–Behmel syndrome

Phenotypic spectrum and tumor risk in Simpson‐Golabi‐Behmel syndrome: Case series and comprehensive literature review

CUGC for Simpson-Golabi-Behmel syndrome (SGBS)

Blepharophimosis with intellectual disability and Helsmoortel‐Van Der Aa Syndrome share episignature and phenotype

Cognitive, Social, and Emotional‐Behavioral Outcomes in Children and Adolescents With Beckwith–Wiedemann Syndrome

A Novel Compound Heterozygous Variant of the SLC12A3 Gene in Gitelman Syndrome Pedigree

Identification by Whole Genome Sequencing and Joint Analysis

A SMARCA2 Mutation in the First Case Report of Nicolaides-Baraitser Syndrome in Latin America: Genotype-Phenotype Correlation

Biallelic variants in GTPBP3: New patients, phenotypic spectrum, and outcome

Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol

Epigenomic and phenotypic characterization of DEGCAGS syndrome

New Insights Into TRMT10A Syndrome: Case Report and Literature Review

Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants

Low‐grade parental gonosomal mosaicism in CHD2 siblings with Smith–Magenis‐like syndrome

[Unusual Facies with Delayed Development and Multiple Malformations in a 14-Month-old Boy].

Novel homozygous OSGEP gene pathogenic variants in two unrelated patients with Galloway-Mowat syndrome: case report and review of the literature

Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics

Diffuse subcortical band heterotopia, periodic limb movements during sleep and a novel "de novo" mutation in the DCX gene

SMC1A epilepsy syndrome: clinical data from a large international cohort

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia